Impact of COVID-19 Towards Antibiotics Consumption in Hospital Queen Elizabeth II
DOI:
https://doi.org/10.51200/bjms.vi1.4316Keywords:
antibiotics, COVID-19, antimicrobial stewardshipAbstract
The COVID-19 pandemic has disrupted antimicrobial stewardship (AMS) activities in Hospital Queen Elizabeth II (HQEII), which has led to a surge in antibiotics consumption, particularly meropenem, vancomycin, piperacillin-tazobactam, ceftazidime, and ceftriaxone. This study aimed to compare the prevalence of antibiotics consumption in HQEII before (2018/2019) and during (2020/2021) the pandemic to explore its impact on antibiotic costs and bacterial resistance.
Downloads
Published
How to Cite
Issue
Section
License
All articles are published under the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, enabling users to read, download, copy, distribute, and adapt the material for non-commercial purposes, provided proper credit is given to the original authors and the source. This model supports transparency, accessibility, and the global exchange of medical knowledge.

